| Ytd | -13.83% | |
| 1y | -36.92% |
| Open | 12.09 | Prev Close | 11.99 | Low | 11.95 | High | 12.20 | Mkt Cap | 254.11M |
| Vol | 44.85K | Avg Vol | 66.23K | EPS | -1.20 | P/E | N/A | Forward P/E | -2.17 |
| Beta | 1.93 | Short Ratio | 12.75 | Inst. Own | 17.05% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-28 | 50-d Avg | 13.73 | 200-d Avg | 14.51 | 1yr Est | 1.00 |
Amarin (NASDAQ: AMRN - Get Free Report) and SCYNEXIS (NASDAQ: SCYX - Get Free Report) are both small
Elanco Animal Health (NYSE: ELAN - Get Free Report) and Amarin (NASDAQ: AMRN - Get Free Report) are
Here is how Amarin (AMRN) and Royalty Pharma (RPRX) have performed compared to their sector so far t
Presentations Expand Understanding of Treatment Adherence, Long-Term Outcomes, Lipoprotein(a), Coagu
DUBLIN and BRIDGEWATER, N.J., Aug. 28, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN)
DUBLIN and BRIDGEWATER, N.J., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN)
JP Morgan analyst Jessica Fye reinstates Amarin Corp (NASDAQ:AMRN) with a Underweight and announc
Amarin Corporation plc (AMRN) Q2 2026 Earnings Call Transcript
AMRN surpasses Q2 earnings estimates despite lower revenues, as cost cuts, rising demand and global
Amarin NASDAQ: AMRN said its second-quarter results reflected progress in its dual commercial strate
Amarin Corp (NASDAQ:AMRN) reported quarterly sales of $42.211 million which missed the analyst conse
Q2 2026 Results Highlight Global Volume Growth, Lower Operating Expenses and Positive Cash Flow For
DUBLIN, Ireland and BRIDGEWATER, N.J., July 15, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NAS
Amarin (AMRN) witnesses a hammer chart pattern, indicating support found by the stock after losing s
Gainers Crinetics Pharmaceuticals (NASDAQ:CRNX) stock increased by 98.9% to $83.59 during Tuesday&#
Amarin Corporation plc (NASDAQ:AMRN), a company committed to advancing the science of cardiovascular
Clinically Validated, Increasingly Prescribed, Widely Reimbursed, and Affordable, VASCEPA Expected t
Here is how Amarin (AMRN) and Amneal Pharmaceuticals (AMRX) have performed compared to their sector
https://www.supremecourt.gov/opinions/25pdf/24-889_5i36.pdf
Amarin Corporation plc (NASDAQ:AMRN) (Amarin), a company committed to advancing the science of cardi
DUBLIN and BRIDGEWATER, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN)
Iovance matches Q1 earnings estimates, but weaker-than-expected Amtagvi and Proleukin sales sent sha
Amarin (AMRN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about t
AMRN beats earnings and sales estimates as Vascepa sales rise and cost cuts take hold, while the par
Amarin Corporation plc (AMRN) Q1 2026 Earnings Call Transcript
Total Revenue Increased Led by Higher International Sales Generated Positive Cash Flow and Reiterate
Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings
Shares of TechTarget, Inc. (NASDAQ: TTGT) rose sharply during Thursday’s session after the company a
Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1
On Thursday, 369 companies hit new 52-week lows.
On Tuesday, 647 companies set new 52-week lows.
On Tuesday, 386 stocks made new 52-week lows.
During the session on Thursday, 461 stocks hit new 52-week lows.
Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss a
Companies Reporting Before The Bell • Janus Henderson Gr (NYSE:JHG) is expected to report quarterly
On Thursday, 1076 companies hit new 52-week lows.
On Thursday, 529 companies set new 52-week lows.
Here's a roundup of top developments in the biotech space over the last 24 hours:
Companies Reporting Before The Bell • Fresh Del Monte Produce (NYSE:FDP) is likely to report qua